# US 8,277,837 B2 · Hemostatic textile

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,837 B2
- Document ID: US8277837B2
- Status: Granted
- Kind: B2
- Application number: 11/650,670
- Filed: 2007-01-08
- Published: 2007-07-12
- Granted: 2012-10-02
- Earliest claimed: 2006-01-11
- Assignees: Entegrion, Inc.; The University of North Carolina at Chapel Hill
- Inventors: Thomas H. Fischer; E. Stan Eskridge, Jr.; William M. Malloy, Jr.; Malloy Evans
- Web page: https://patentgrep.com/patent/US8277837B2

## CPC

- A61F 13/01042: {Absorbency}
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61F 13/00072: {Packaging of dressings}
- A61F 13/00991: {for treating webs, e.g. for moisturising, coating, impregnating or applying powder}
- A61F 13/01012: {being made of natural material, e.g. cellulose-, protein-, collagen-based}
- A61F 13/01017: {synthetic, e.g. polymer based}
- A61L 15/16: Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L 15/18: containing inorganic materials
- A61L 15/20: containing organic materials
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61F 2013/00089: {Wound bandages (A61F2013/00361 takes precedence;)}
- A61F 2013/00463: {haemostatic}
- A61K 36/899: Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61L 2400/04: Materials for stopping bleeding
- C08K 7/14: Glass
- D02G 3/18: from glass or the like
- Y10T 442/30: Woven fabric [i.e., woven strand or strip material]
- Y10T 442/40: Knit fabric [i.e., knit strand or strip material]
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- D02G: CRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention is directed to a hemostatic textile, comprising: a material comprising a combination of glass fibers and one or more secondary fibers selected from the group consisting of silk fibers; ceramic fibers; raw or regenerated bamboo fibers; cotton fibers; rayon fibers; linen fibers; ramie fibers; jute fibers; sisal fibers; flax fibers; soybean fibers; corn fibers; hemp fibers; lyocel fibers; wool; lactide and/or glycolide polymers; lactide/glycolide copolymers; silicate fibers; polyamide fibers; feldspar fibers; zeolite fibers, zeolite-containing fibers, acetate fibers; and combinations thereof; the hemostatic textile capable of activating hemostatic systems in the body when applied to a wound. Additional cofactors such as thrombin and hemostatic agents such as RL platelets, RL blood cells; fibrin, fibrinogen, and combinations thereof may also be incorporated into the textile. The invention is also directed to methods of producing the textile, and methods of using the textile to stop bleeding.

## Claims

### Claim 1

A hemostatic textile, comprising:
a material comprising glass fibers and raw or regenerated bamboo fibers co-woven or knitted together, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 0.1% to about 99.9% by weight glass fibers and from about 99.9% to about 0.1% by weight raw or regenerated bamboo fibers, based on the total weight of said textile; and
thrombin or a fraction comprising thrombin;
said hemostatic textile capable of activating hemostatic systems in the body when applied to a wound.

### Claim 2 (depends on 1)

The hemostatic textile of claim 1, wherein said fraction comprising thrombin further comprises one or more coagulation factors selected from the group consisting of factor XII, factor XIIa, factor XI, factor XIa, factor XIII, factor XIIIa, factor IX, factor IXa, factor VIII, factor VIIIa, factor vWF, factor V, factor Va, factor X, factor Xa, and combinations thereof.

### Claim 3 (depends on 1)

The hemostatic textile of claim 1, wherein said fraction further comprises a vasoactive agent.

### Claim 4 (depends on 3)

The hemostatic textile of claim 3, wherein said vasoactive agent is selected from the group consisting of endothelins, thromoboxanes, NO scavengers, and combinations thereof.

### Claim 5 (depends on 1)

The hemostatic textile of claim 1, further comprising a preservative selected from the group consisting of glycerol, propanediol, polyoxyethylene glycol (PEG), trehalose, and combinations thereof.

### Claim 6 (depends on 1)

The hemostatic textile of claim 1, wherein said fraction comprising thrombin is a partially purified plasma fraction containing thrombin IIa.

### Claim 7 (depends on 1)

The hemostatic textile of claim 1, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 30% to about 80% by weight glass fibers and from about 70% to about 20% by weight raw or regenerated bamboo fibers, based on the total weight of said textile.

### Claim 8 (depends on 1)

The hemostatic textile of claim 1, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 50% to about 80% by weight glass fibers and from about 50% to about 20% by weight raw or regenerated bamboo fibers, based on the total weight of said textile.

### Claim 9 (depends on 1)

The hemostatic textile of claim 1, wherein said thrombin or a fraction comprising thrombin comprises from about 0.01% to about 10% by weight, based on the total weight of said textile.

### Claim 10 (depends on 1)

The hemostatic textile of claim 1, wherein said thrombin or a fraction comprising thrombin comprises from about 0.05% to about 7% by weight, based on the total weight of said textile.

### Claim 11 (depends on 1)

The hemostatic textile of claim 1, wherein said thrombin or a fraction comprising thrombin comprises from about 0.1% to about 5% by weight, based on the total weight of said textile.

### Claim 12 (depends on 1)

The hemostatic textile of claim 1, further comprising one or more additional agents selected from the group consisting of skin conditioners, anti-inflammatory agents, analgesics, antimicrobial or antifungal agents, vasoconstrictors, growth factors, anti-scar agents, cauterizing agents, dehydrating agents, prothrombotic agents, and combinations thereof.

### Claim 13 (depends on 1)

The hemostatic textile of claim 1, wherein said textile material is in a woven form.

### Claim 14 (depends on 1)

The hemostatic textile of claim 1, wherein said hemostatic textile is an article of clothing or a liner for an article of clothing.

### Claim 15

A hemostatic textile, comprising:
a material comprising a combination of about 65% by weight glass fibers and about 35% by weight raw or regenerated bamboo fibers, based on the total weight of said textile wherein the glass fibers and the raw or regenerated bamboo fibers are co-woven or knitted together; and
from about 0.1% to about 5% by weight of thrombin or a fraction comprising thrombin based on the total weight of said textile;
said hemostatic textile capable of activating hemostatic systems in the body when applied to a wound.

### Claim 16

A hemostatic textile, comprising:
a material comprising glass fibers and raw or regenerated bamboo fibers co-woven or knitted together, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 0.1% to about 99.9% by weight glass fibers and from about 99.9% to about 0.1% by weight raw or regenerated bamboo fibers, based on the total weight of said textile; and
one or more hemostatic agents selected from the group consisting of rehydrated lyophilized (RL) platelets, RL blood cells, fibrin, and fibrinogen;
said hemostatic textile capable of activating hemostatic systems in the body when applied to a wound.

### Claim 17 (depends on 16)

The hemostatic textile of claim 16, further comprising one or more coagulation factors selected from the group consisting of factor XII, factor XIIa, factor XI, factor XIa, factor XIII, factor XIIIa, factor IX, factor IXa, factor VIII, factor VIIIa, factor vWF, factor V, factor Va, factor X, factor Xa, and combinations thereof.

### Claim 18 (depends on 16)

The hemostatic textile of claim 16, further comprising a vasoactive agent.

### Claim 19 (depends on 18)

The hemostatic textile of claim 18, wherein said vasoactive agent is selected from the group consisting of endothelins, thromoboxanes, NO scavengers, and combinations thereof.

### Claim 20 (depends on 16)

The hemostatic textile of claim 16, further comprising a preservative selected from the group consisting of glycerol, propanediol, polyoxyethylene glycol (PEG), trehalose, and combinations thereof.

### Claim 21 (depends on 16)

The hemostatic textile of claim 16, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 30% to about 80% by weight glass fibers and from about 70% to about 20% by weight raw or regenerated bamboo fibers, based on the total weight of said textile.

### Claim 22 (depends on 16)

The hemostatic textile of claim 16, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 50% to about 80% by weight glass fibers and from about 50% to about 20% by weight raw or regenerated bamboo fibers, based on the total weight of said textile.

### Claim 23 (depends on 16)

The hemostatic textile of claim 16, wherein said RL platelets or said RL blood cells comprise from about 0.1% to about 20% by weight, based on the total weight of said textile.

### Claim 24 (depends on 16)

The hemostatic textile of claim 16, wherein said fibrin or fibrinogen comprises from about 0.1% to about 5% by weight, based on the total weight of said textile.

### Claim 25 (depends on 16)

The hemostatic textile of claim 16, further comprising one or more additional agents selected from the group consisting of skin conditioners, anti-inflammatory agents, analgesics, antimicrobial or antifungal agents, vasoconstrictors, growth factors, anti-scar agents, cauterizing agents, dehydrating agents, prothrombotic agents, and combinations thereof.

### Claim 26 (depends on 16)

The hemostatic textile of claim 16, wherein said textile material is in a woven form.

### Claim 27 (depends on 16)

The hemostatic textile of claim 16, wherein said hemostatic textile is an article of clothing or a liner for an article of clothing.

### Claim 28

A hemostatic textile, comprising:
a material comprising a combination of about 65% by weight glass fibers and about 35% by weight raw or regenerated bamboo fibers, based on the total weight of said textile, wherein the glass fibers and the raw or regenerated bamboo fibers are co-woven or knitted together; and
one or more hemostatic agents selected from the group consisting of rehydrated lyophilized (RL) platelets, RL blood cells, fibrin, and fibrinogen, wherein said RL platelets and said RL blood cells comprise from about 0.1% to about 20% by weight and said fibrin and said fibrinogen comprise from about 0.1% to about 5% by weight, based on the total weight of said textile;
said hemostatic textile capable of activating hemostatic systems in the body when applied to a wound.

### Claim 29

A hemostatic textile, comprising:
a material comprising glass fibers and raw or regenerated bamboo fibers co-woven or knitted together, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 0.1% to about 99.9% by weight glass fibers and from about 99.9% to about 0.1% by weight raw or regenerated bamboo fibers, based on the total weight of said textile; and
thrombin or a fraction containing thrombin; and
one or more hemostatic agents selected from the group consisting of rehydrated lyophilized (RL) platelets, RL blood cells, fibrin, and fibrinogen;
said hemostatic textile capable of activating hemostatic systems in the body when applied to a wound.

### Claim 30 (depends on 29)

The hemostatic textile of claim 29, wherein said fraction further comprises one or more coagulation factors selected from the group consisting of factor XII, factor XIIa, factor XI, factor XIa, factor XIII, factor XIIIa, factor IX, factor IXa, factor VIII, factor VIIIa, factor vWF, factor V, factor Va, factor X, factor Xa, and combinations thereof.

### Claim 31 (depends on 29)

The hemostatic textile of claim 29, wherein said fraction further comprises a vasoactive agent.

### Claim 32 (depends on 31)

The hemostatic textile of claim 31, wherein said vasoactive agent is selected from the group consisting of endothelins, thromoboxanes, NO scavengers, and combinations thereof.

### Claim 33 (depends on 29)

The hemostatic textile of claim 29, further comprising a preservative selected from the group consisting of glycerol, propanediol, polyoxyethylene glycol (PEG), trehalose, and combinations thereof.

### Claim 34 (depends on 29)

The hemostatic textile of claim 29, wherein said fraction comprising thrombin is a partially purified plasma fraction containing thrombin IIa.

### Claim 35 (depends on 29)

The hemostatic textile of claim 29, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 30% to about 80% by weight glass fibers and from about 70% to about 20% by weight raw or regenerated bamboo fibers, based on the total weight of said textile.

### Claim 36 (depends on 29)

The hemostatic textile of claim 29, wherein the relative amounts of said glass fibers and said raw or regenerated bamboo fibers range from about 50% to about 80% by weight glass fibers and from about 50% to about 20% by weight raw or regenerated bamboo fibers, based on the total weight of said textile.

### Claim 37 (depends on 29)

The hemostatic textile of claim 29, wherein said thrombin or a fraction comprising thrombin comprises from about 0.01% to about 10% by weight, based on the total weight of said textile.

### Claim 38 (depends on 29)

The hemostatic textile of claim 29, wherein said thrombin or a fraction comprising thrombin comprises from about 0.05% to about 7% by weight, based on the total weight of said textile.

### Claim 39 (depends on 29)

The hemostatic textile of claim 29, wherein said thrombin or a fraction comprising thrombin comprises from about 0.1% to about 5% by weight, based on the total weight of said textile.

### Claim 40 (depends on 29)

The hemostatic textile of claim 29, wherein said RL platelets or said RL blood cells comprise from about 0.1% to about 20% by weight, based on the total weight of said textile.

### Claim 41 (depends on 29)

The hemostatic textile of claim 29, wherein said fibrin or fibrinogen comprises from about 0.1% to about 5% by weight, based on the total weight of said textile.

### Claim 42 (depends on 29)

The hemostatic textile of claim 29, further comprising one or more additional agents selected from the group consisting of skin conditioners, anti-inflammatory agents, analgesics, antimicrobial or antifungal agents, vasoconstrictors, growth factors, anti-scar agents, cauterizing agents, dehydrating agents, prothrombotic agents, and combinations thereof.

### Claim 43 (depends on 29)

The hemostatic textile of claim 29 in a woven form.

### Claim 44 (depends on 29)

The hemostatic textile of claim 29, wherein said hemostatic textile is an article of clothing or a liner for an article of clothing.

### Claim 45

A hemostatic textile, comprising:
a textile material comprising a combination of about 65% by weight glass fibers and about 35% by weight raw or regenerated bamboo fibers, based on the total weight of said textile wherein the glass fibers and the raw or regenerated bamboo fibers are co-woven or knitted together;
from about 0.1% to about 5% by weight of thrombin or a fraction comprising thrombin based on the total weight of said textile; and
one or more hemostatic agents selected from the group consisting of rehydrated lyophilized (RL) platelets, RL blood cells, fibrin, and fibrinogen, wherein said RL platelets and said RL blood cells comprise from about 0.1% to about 20% by weight and said fibrin and said fibrinogen comprise from about 0.1% to about 5% by weight, based on the total weight of said textile;
said hemostatic textile capable of activating hemostatic systems in the body when applied to a wound.
